Trial Information
Effects of Physical Activity on the Endothelial and Cardiac Function of Patients With Renal Cell Carcinoma Receiving a Thyrosine Kinase Inhibitor (Sunitinib)
Inclusion Criteria:
- 18 to 75 years
- Understanding of written German
- Treatment with Sunitinib
- Ability to walk
Exclusion Criteria:
- Cardiovascular, pulmonary or osteoarticular disease which can be aggravated by
exercise
- BMI < 18 or > 30
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care
Outcome Measure:
Fatigue
Outcome Time Frame:
12 weeks
Safety Issue:
No
Authority:
Germany: Ethics Commission
Study ID:
SUIR8687
NCT ID:
NCT00869011
Start Date:
December 2009
Completion Date:
Related Keywords:
- Renal Cell Carcinoma
- Cancer
- renal cell carcinoma
- fatigue
- exercise
- Carcinoma
- Carcinoma, Renal Cell